Requires veterinarians to provide consultations to animal owners when a drug is prescribed and dispensed for that annual patient.
Plain English Summary
AI-generatedRI Bill Summary: Veterinarian Drug Consultations
This bill would require veterinarians in Rhode Island to have a consultation with a pet or animal owner whenever they prescribe and dispense medication directly to that patient during an annual visit. In other words, if your vet writes a prescription *and* hands you the medication right there at the office, they would be legally required to talk with you about that drug — explaining what it is, how to use it, and any other relevant information.
The bill appears to be modeled after similar consultation requirements that already exist for human pharmacists, who are generally required to counsel patients when dispensing medications. This would extend a comparable standard of communication to the veterinary setting, ensuring animal owners receive important information about any drugs their pets are given.
This bill would primarily affect pet owners and veterinarians across Rhode Island. Animal owners would benefit from being formally informed about the medications their pets receive, which could help prevent errors in administration and improve animal health outcomes. Veterinarians would take on the added responsibility of ensuring these consultations occur and are documented as part of their practice.
The bill is currently in the early stages of the legislative process. It was referred to the House Corporations Committee, and a scheduled hearing in February 2026 was postponed. The committee has since recommended the bill be held for further study, meaning it has not yet moved forward for a full vote.
This summary is AI-generated for informational purposes. Always refer to the official bill text for legal accuracy.
Sponsors
Legislative History
Committee recommended measure be held for further study
Mar 3, 2026Scheduled for hearing and/or consideration (03/03/2026)
Feb 27, 2026Meeting postponed (02/24/2026)
Feb 23, 2026Scheduled for hearing and/or consideration
Feb 19, 2026Introduced, referred to House Corporations
Feb 11, 2026